Samsung Biologics union backs strike action amid pay talks deadlock, reports say

Workers at Samsung Biologics voted to authorize strike action, paving the way for the company's first-ever strike. This creates near-term operational risk to manufacturing and contract development/production activities and is a headwind to near-term revenue, with potential to move the stock low single-digit percentages (roughly 1-3%). Monitor strike timing, scope and any company negotiations for updates.

Analysis

Workers at Samsung Biologics voted to authorize strike action, paving the way for the company's first-ever strike. This creates near-term operational risk to manufacturing and contract development/production activities and is a headwind to near-term revenue, with potential to move the stock low single-digit percentages (roughly 1-3%). Monitor strike timing, scope and any company negotiations for updates.